New supplement cocktail aims to stop preterm labor
NCT ID NCT07305519
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a daily supplement containing magnesium, palmitoylethanolamide, high-molecular-weight hyaluronic acid, vitamin B6, and vitamin D can help prevent preterm birth in women at risk. The supplement is given alongside standard vaginal progesterone. The trial will enroll 150 pregnant women with a short cervix (between 15 and 30 mm) and follow them until delivery to see if the combination reduces births before 37 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
a combination oral supplement containing magnesium, palmitoylethanolamide, high-molecular-weight hyaluronic acid, vitamin B6, and vitamin D, plus vaginal progesterone
What this could lead to
If it works, this could offer a simple, safe supplement-based way to reduce the risk of preterm birth in women with a short cervix.
What could go wrong
This is a relatively small, early-stage trial (150 participants) and the supplement is added to standard care, so any added benefit may be modest. Results may not apply to all at-risk women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM LABOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Policlinico Umberto I
RECRUITINGRome, RM, 00161, Italy